Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 671800 in Seasonal Allergic Rhinitis
NCT01007721Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BI-671800 in seasonal allergic rhinitis (SAR), sponsored by Boehringer Ingelheim. Started Oct 2009; status: completed.
02
Drugs
BI-671800
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01007721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01007721.